Phibro Animal Health Q4 2024 Adj. EPS $0.41 Beats $0.33 Estimate, Sales $273.200M Beat $263.245M Estimate
Portfolio Pulse from Benzinga Newsdesk
Phibro Animal Health (NASDAQ:PAHC) reported Q4 2024 earnings of $0.41 per share, surpassing the $0.33 estimate, and sales of $273.2M, exceeding the $263.245M estimate. This marks a 7.89% increase in EPS and a 7.14% rise in sales compared to the previous year.
August 28, 2024 | 8:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Phibro Animal Health's Q4 2024 earnings and sales exceeded analyst expectations, with EPS at $0.41 and sales at $273.2M, indicating strong financial performance and growth.
Phibro Animal Health's earnings per share and sales both exceeded analyst estimates, indicating better-than-expected financial performance. The EPS of $0.41 was 24.24% above the estimate, and sales were 3.78% higher than expected. This positive earnings surprise is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100